PacketFabric Offers Connectivity to IBM Cloud
Mar 06, 2018 13:35 pm UTC| Business
CULVER CITY, Calif., March 06, 2018 -- PacketFabric, the highly scalable Connectivity-as-a-Service (CaaS) platform and a member of the NantWorks ecosystem of companies, today announces that it now offers direct access...
Bavarian Nordic Announces Additional Positive Data from a Phase 2 Study of its Universal RSV Vaccine
Mar 06, 2018 13:33 pm UTC| Business
Presence of antibodies in nasal mucosa suggest vaccine-induced immune protection at source of infection IgA antibodies against RSV observed in both serum and mucosa of vaccinated individuals COPENHAGEN, Denmark,...
Brazil Minerals, Inc. Adds Premier Gold Areas Drilling Campaign Planned for Late 2018
Mar 06, 2018 13:33 pm UTC| Business
PASADENA, Calif., March 06, 2018 -- Via OTC PR Wire -- Brazil Minerals, Inc. (OTC:BMIX) (the "Company" or "Brazil Minerals") announced today that its subsidiary, Jupiter Gold Corporation ("Jupiter Gold"), has been...
Infrax (IFXY) Announces Shareholder Update
Mar 06, 2018 13:32 pm UTC| Business
Saint Petersburg, FL, March 06, 2018 -- Infrax Systems (OTC: IFXY), a global provider of Internet of Things, Blockchain technology consulting and ICO consulting services, announces shareholder update which includes its...
Abattis Rebrands as a Downstream Solutions Provider for the Cannabis Market
Mar 06, 2018 13:31 pm UTC| Business
VANCOUVER, British Columbia, March 06, 2018 -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (CSE:ATT) (OTC:ATTBF) is pleased to announce it has officially rebranded itself as a one-stop provider of downstream...
Relievant Appoints Christopher Geyen Chief Financial Officer
Mar 06, 2018 13:31 pm UTC| Business
SUNNYVALE, Calif., March 06, 2018 -- Relievant Medsystems, a privately held medical device company that has developed the Intracept® Procedure, a minimally invasive and clinically proven approach for the treatment of...
Corvus Pharmaceuticals to Present at the Cowen and Company 38th Annual Health Care Conference 2018
Mar 06, 2018 13:31 pm UTC| Business
BURLINGAME, Calif., March 06, 2018 -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies,...
South Africa’s plan to move away from coal: 8 steps to make it succeed
Germany lowers voting age to 16 for the European elections
IceCube researchers detect a rare type of energetic neutrino sent from powerful astronomical objects